About the disease
About the test
The Molecular Diagnostic Unit can now offer genetic testing for hypertrophic cardiomyopathy in Maine Coon and Ragdoll cats. We have developed PCR assays to quickly and accurately identify the two MYBPC3 gene mutations currently linked with HCM in Maine Coon (A31P) and Ragdoll (R820W) cats.
These mutations cause amino acid changes within the cardiac myosin binding protein and are believed to alter the protein structure and function. It is possible to detect whether a cat has one copy of the defective gene (Heterozygous) or two copies (Homozygous).
There is evidence that the presence of the mutant gene puts cats at greater risk of developing HCM, and the risk for Homozygous cats appears to be greater than that for Heterozygous cats, but this correlation is not perfect. This may be because other, as yet unidentified, genetic mutations can also cause HCM or modify the risk.
There is some evidence that cats Homozygous for the mutant gene are more likely to develop moderate to severe disease earlier in life when compared to Heterozygous cats. Results suggest that the prevalence of the A31P mutation in the Maine Coon population is around 26%.
Interpretation of results
A Normal result on the Maine Coon HCM genetic test means that the cat does not have the genetic mutation. It is possible that some cats may go on to develop cardiac disease due to other, as yet unidentified genetic mutations.
A Heterozygous or Homozygous result on the Maine Coon genetic test means that the cat carries either one (Heterozygous) or two (Homozygous) mutated copies of the MYBPC3 gene and is at greater risk of developing cardiac disease. Cats that are Homozygous for the genetic mutation are thought likely to develop HCM.
Consideration should be given to screening cats with a positive HCM genetic test result by ultrasound to determine the disease status and progression.
Each certificate we issue will specify whether the cat is Normal, Heterozygous or Homozygous for the Maine Coon HCM mutation.
The gene test combined with ultrasound can assist breeders in deciding whether or not to use cats for breeding. Generally Homozygous affected cats should not be used for breeding because they are certain to pass on the genetic mutation, which will put their offspring at increased risk of developing HCM.
There is a 50% probability of a Heterozygous cat passing on the genetic mutation when bred with a HCM negative cat. In such cases the offspring should be screened for the genetic mutation and those identified as negative used for future breeding. This strategy can be used as part of a breeding programme to eliminate the defective gene from the Maine Coon population.
Frequently Asked Questions
I am a vet, why does one of my clients need me to send in their cat's sample for genetic testing?
International Cat Care run some “negative genetic registers” and the GCCF run some “active registers”. For cats to be placed on these registers the sample (mouth swab or blood sample) MUST be taken by a vet who confirms the cat’s identity using its microchip number. The microchip number must be written on the submission form AND sample.
We have a dedicated submission form for this purpose, which both the owner and vet must complete. The certificate will state that the cat’s identity was confirmed by a vet and you can use this to register the cat with the ICC negative or GCCF active registers.
If a breeder DOES NOT want their cat to go on these registers then they can take a mouth swab and submit it directly to the lab.
Click here to download -